Systemic immune activation leads to neuroinflammation and sickness behavior in mice

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Biesmans, Steven ^a,b   Meert, Theo F ^a   Bouwknecht, Jan A ^b   Acton, Paul D ^b   Davoodi, Nima ^a   De Haes, Patrick ^b   Kuijlaars, Jacobine ^b   Langlois, Xavier ^b   Matthews, Liam J R ^b   Ver Donck, Luc ^b   Hellings, Niels ^a   Nuydens, Rony ^b  

^a HASSELT UNIVERSITY   (Belgium)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING ADAPTER MOLECULE; CALCIUM BINDING PROTEIN; CYTOKINE; GLIAL FIBRILLARY ACIDIC PROTEIN; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; AIF1 PROTEIN, MOUSE; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BIOLUMINESCENCE; BRAIN REGION; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; ILLNESS BEHAVIOR; IMMUNOREACTIVITY; MALE; MICROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ANIMAL BEHAVIOR; BLOOD; BRAIN; CHEMISTRY; CYTOLOGY; DECISION MAKING; DISEASE MODEL; FEEDING BEHAVIOR; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INFLAMMATION; LUMINESCENCE; METABOLISM; NERVE CELL; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; ASTROCYTES; BEHAVIOR, ANIMAL; BRAIN; CALCIUM-BINDING PROTEINS; CHOICE BEHAVIOR; CYTOKINES; DEPRESSION; DISEASE MODELS, ANIMAL; FEEDING BEHAVIOR; ILLNESS BEHAVIOR; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIPOPOLYSACCHARIDES; LUMINESCENCE; MALE; MICE; MICE, TRANSGENIC; MICROFILAMENT PROTEINS; MICROGLIA; NEURONS; SUCROSE;

EID: 84880849626     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/271359     Document Type: Article

References (67)

1. Kessler R. C., Berglund P., Demler O., Jin R., Merikangas K. R., Walters E. E., Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry 2005 62 6 593 602 2-s2.0-20344385026 10.1001/archpsyc.62.6.593 (Pubitemid 40973434)
2. Mathers C. D., Loncar D., Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine 2006 3 11 2011 2030 2-s2.0-33845338724 10.1371/journal.pmed.0030442 (Pubitemid 44875937)
3. Shelton R. C., The molecular neurobiology of depression. Psychiatric Clinics of North America 2007 30 1 1 11 2-s2.0-33847691902 10.1016/j.psc.2006. 12.005 (Pubitemid 46386302)
4. Schiepers O. J. G., Wichers M. C., Maes M., Cytokines and major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2005 29 2 201 217 2-s2.0-13444292316 10.1016/j.pnpbp.2004.11.003 (Pubitemid 40202906)
5. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E. K., Lanctôt K. L., A meta-analysis of cytokines in major depression. Biological Psychiatry 2010 67 5 446 457 2-s2.0-75849155537 10.1016/j.biopsych. 2009.09.033
6. Blume J., Douglas S. D., Evans D. L., Immune suppression and immune activation in depression. Brain, Behavior, and Immunity 2011 25 2 221 229 2-s2.0-78651417057 10.1016/j.bbi.2010.10.008
7. Howren M. B., Lamkin D. M., Suls J., Associations of depression with c-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosomatic Medicine 2009 71 2 171 186 2-s2.0-65649152524 10.1097/PSY.0b013e3181907c1b
8. Katz P. P., Yelin E. H., Prevalence and correlates of depressive symptoms among persons with rheumatoid arthritis. Journal of Rheumatology 1993 20 5 790 796 2-s2.0-0027158275 (Pubitemid 23158471)
9. Dickens C., McGowan L., Clark-Carter D., Creed F., Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosomatic Medicine 2002 64 1 52 60 2-s2.0-0036173175 (Pubitemid 34137399)
10. Khawaja I. S., Westermeyer J. J., Gajwani P., Feinstein R. E., Depression and coronary artery disease: the association, mechanisms and therapeutic implications. Psychiatry 2009 6 1 2-s2.0-65549153569
11. Zellweger M. J., Osterwalder R. H., Langewitz W., Pfisterer M. E., Coronary artery disease and depression. European Heart Journal 2004 25 1 3 9 2-s2.0-0347988274 10.1016/j.ehj.2003.09.009 (Pubitemid 38055586)
12. Schwartz J. A., Speed N. M., Brunberg J. A., Brewer T. L., Brown M., Greden J. F., Depression in stroke rehabilitation. Biological Psychiatry 1993 33 10 694 699 2-s2.0-0027216690 10.1016/0006-3223(93)90118-W (Pubitemid 23205325)
13. Anderson R. J., Freedland K. E., Clouse R. E., Lustman P. J., The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001 24 6 1069 1078 2-s2.0-0035374580 (Pubitemid 33716379)
14. Petry N. M., Barry D., Pietrzak R. H., Wagner J. A., Overweight and obesity are associated with psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions. Psychosomatic Medicine 2008 70 3 288 297 2-s2.0-42149092160 10.1097/PSY.0b013e3181651651 (Pubitemid 351543491)
15. Capuron L., Ravaud A., Dantzer R., Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon α -2b therapy. Journal of Clinical Oncology 2000 18 10 2143 2151 2-s2.0-0034079672 (Pubitemid 30324368)
16. Raison C. L., Capuron L., Miller A. H., Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology 2006 27 1 24 31 2-s2.0-30544445602 10.1016/j.it.2005.11.006 (Pubitemid 43083561)
17. Bonaccorso S., Puzella A., Marino V., Pasquini M., Biondi M., Artini M., Almerighi C., Levrero M., Egyed B., Bosmans E., Meltzer H. Y., Maes M., Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Research 2001 105 1-2 45 55 2-s2.0-0035894157 10.1016/S0165-1781(01)00315-8 (Pubitemid 34015882)
18. Hart B. L., Biological basis of the behavior of sick animals. Neuroscience and Biobehavioral Reviews 1988 12 2 123 137 2-s2.0-0024159821 (Pubitemid 19268745)
19. Kent S., Bluthe R.-M., Kelley K. W., Dantzer R., Sickness behavior as a new target for drug development. Trends in Pharmacological Sciences 1992 13 1 24 28 2-s2.0-0026512096 10.1016/0165-6147(92)90012-U
20. Dantzer R., O'Connor J. C., Freund G. G., Johnson R. W., Kelley K. W., From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience 2008 9 1 46 56 2-s2.0-37249094173 10.1038/nrn2297 (Pubitemid 350295688)
21. Krishnadas R., Cavanagh J., Depression: an inflammatory illness? Journal of Neurology, Neurosurgery and Psychiatry 2012 83 5 495 502 2-s2.0-84859709075 10.1136/jnnp-2011-301779
22. Henry C. J., Huang Y., Wynne A., Hanke M., Himler J., Bailey M. T., Sheridan J. F., Godbout J. P., Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. Journal of Neuroinflammation 2008 5, article 15 2-s2.0-44949225039 10.1186/1742-2094-5-15 (Pubitemid 351803827)
23. Frenois F., Moreau M., O'Connor J., Lawson M., Micon C., Lestage J., Kelley K. W., Dantzer R., Castanon N., Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 2007 32 5 516 531 2-s2.0-34248581135 10.1016/j.psyneuen.2007.03.005 (Pubitemid 46756007)
24. O'Connor J. C., Lawson M. A., André C., Moreau M., Lestage J., Castanon N., Kelley K. W., Dantzer R., Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Molecular Psychiatry 2009 14 5 511 522 2-s2.0-65349135346 10.1038/sj.mp.4002148
25. Yirmiya R., Endotoxin produces a depressive-like episode in rats. Brain Research 1996 711 1-2 163 174 2-s2.0-0029962322 10.1016/0006-8993(95)01415-2 (Pubitemid 26080239)
26. Zhu C.-B., Lindler K. M., Owens A. W., Daws L. C., Blakely R. D., Hewlett W. A., Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology 2010 35 13 2510 2520 2-s2.0-78149466027 10.1038/npp.2010.116
27. Berg B. M., Godbout J. P., Kelley K. W., Johnson R. W., α -Tocopherol attenuates lipopolysaccharide-induced sickness behavior in mice. Brain, Behavior, and Immunity 2004 18 2 149 157 2-s2.0-0842349248 10.1016/S0889-1591(03)00113-2 (Pubitemid 38169159)
28. Tonelli L. H., Holmes A., Postolache T. T., Intranasal immune challenge induces sex-dependent depressive-like behavior and cytokine expression in the brain. Neuropsychopharmacology 2008 33 5 1038 1048 2-s2.0-40549112335 10.1038/sj.npp.1301488 (Pubitemid 351367545)
29. Godbout J. P., Chen J., Abraham J., Richwine A. F., Berg B. M., Kelley K. W., Johnson R. W., Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB Journal 2005 19 10 1329 1331 2-s2.0-23444443814 10.1096/fj.05-3776fje (Pubitemid 41113739)
30. Godbout J. P., Moreau M., Lestage J., Chen J., Sparkman N. L., O'Connor J., Castanon N., Kelley K. W., Dantzer R., Johnson R. W., Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system. Neuropsychopharmacology 2008 33 10 2341 2351 2-s2.0-49549087762 10.1038/sj.npp.1301649
31. Zhu L., Ramboz S., Hewitt D., Boring L., Grass D. S., Purchio A. F., Non-invasive imaging of GFAP expression after neuronal damage in mice. Neuroscience Letters 2004 367 2 210 212 2-s2.0-4344659039 10.1016/j.neulet.2004. 06.020 (Pubitemid 39141229)
32. Kadurugamuwa J. L., Modi K., Coquoz O., Rice B., Smith S., Contag P. R., Purchio T., Reduction of astrogliosis by early treatment of pneumococcal meningitis measured by simultaneous imaging, in vivo, of the pathogen and host response. Infection and Immunity 2005 73 12 7836 7843 2-s2.0-28444481360 10.1128/IAI.73.12.7836-7843.2005 (Pubitemid 41740266)
33. Lee J., Borboa A. K., Baird A., Eliceiri B. P., Non-invasive quantification of brain tumor-induced astrogliosis. BMC Neuroscience 2011 12, article 9 2-s2.0-78651490601 10.1186/1471-2202-12-9
34. Tamgüney G., Francis K. P., Giles K., Lemus A., DeArmond S. J., Prusiner S. B., Measuring prions by bioluminescence imaging. Proceedings of the National Academy of Sciences of the United States of America 2009 106 35 15002 15006 2-s2.0-70349298441 10.1073/pnas.0907339106
35. Cordeau P. Jr., Lalancette-Hébert M., Weng Y. C., Kriz J., Live imaging of neuroinflammation reveals sex and estrogen effects on astrocyte response to ischemic injury. Stroke 2008 39 3 935 942 2-s2.0-41249092093 10.1161/STROKEAHA.107.501460 (Pubitemid 351619580)
36. Luo J., Ho P., Steinman L., Wyss-Coray T., Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease. Journal of Neuroinflammation 2008 5, article 6 2-s2.0-41049089072 10.1186/1742-2094-5-6 (Pubitemid 351420120)
37. Erickson M. A., Banks W. A., Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: multiplex quantification with path analysis. Brain, Behavior, and Immunity 2011 25 8 1637 1648 2-s2.0-80053900477 10.1016/j.bbi.2011.06.006
38. Van Der Heyden J. A. M., Zethof T. J. J., Olivier B., Stress-induced hyperthermia in singly housed mice. Physiology and Behavior 1997 62 3 463 470 2-s2.0-0030921751 10.1016/S0031-9384(97)00157-1 (Pubitemid 27376279)
39. Vasey M. W., Thayer J. F., The continuing problem of false positives in repeated measures ANOVA in psychophysiology: a multivariate solution. Psychophysiology 1987 24 4 479 486 2-s2.0-0023183119 (Pubitemid 17114214)
40. Che Y., Wang J.-F., Shao L., Young L. T., Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. Journal of Psychiatry and Neuroscience 2010 35 5 296 302 2-s2.0-77956549615 10.1503/jpn.090083
41. Hanson N. D., Owens M. J., Nemeroff C. B., Depression, antidepressants, and neurogenesis: a critical reappraisal. Neuropsychopharmacology 2011 36 13 2589 2602 2-s2.0-80855123608 10.1038/npp.2011.220
42. Surget A., Tanti A., Leonardo E. D., Laugeray A., Rainer Q., Touma C., Palme R., Griebel G., Ibarguen-Vargas Y., Hen R., Belzung C., Antidepressants recruit new neurons to improve stress response regulation. Molecular Psychiatry 2011 16 12 1177 1188 2-s2.0-81755172044 10.1038/mp.2011.48
43. Chen J., Buchanan J. B., Sparkman N. L., Godbout J. P., Freund G. G., Johnson R. W., Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brain, Behavior, and Immunity 2008 22 3 301 311 2-s2.0-38649119160 10.1016/j.bbi.2007.08.014 (Pubitemid 351172703)
44. Buchanan J. B., Sparkman N. L., Johnson R. W., Methamphetamine sensitization attenuates the febrile and neuroinflammatory response to a subsequent peripheral immune stimulus. Brain, Behavior, and Immunity 2010 24 3 502 511 2-s2.0-77951620051 10.1016/j.bbi.2009.12.008
45. Ridet J. L., Malhotra S. K., Privat A., Gage F. H., Reactive astrocytes: cellular and molecular cues to biological function. Trends in Neurosciences 1997 20 12 570 577 2-s2.0-0030697366 10.1016/S0166-2236(97)01139-9 (Pubitemid 27508969)
46. de Heredia L. L., Gengatharan A., Foster J., Mather S., Magoulas C., Bioluminescence imaging of the brain response to acute inflammation in living C/EBP reporter mice. Neuroscience Letters 2011 497 2 134 138 2-s2.0-79956328116 10.1016/j.neulet.2011.04.046
47. Alm A. S., Li K., Chen H., Wang D., Andersson R., Wang X., Variation of lipopolysaccharide-induced acute lung injury in eight strains of mice. Respiratory Physiology and Neurobiology 2010 171 2 157 164 2-s2.0-77950988936 10.1016/j.resp.2010.02.009
48. Browne C. A., O'Brien F. E., Connor T. J., Dinan T. G., Cryan J. F., Differential lipopolysaccharide-induced immune alterations in the hippocampus of two mouse strains: effects of stress. Neuroscience 2012 225 237 248 10.1016/j.neuroscience.2012.08.031
49. Ito D., Imai Y., Ohsawa K., Nakajima K., Fukuuchi Y., Kohsaka S., Microglia-specific localisation of a novel calcium binding protein, Iba1. Molecular Brain Research 1998 57 1 1 9 2-s2.0-0032102358 10.1016/S0169-328X(98) 00040-0 (Pubitemid 28279554)
50. Ito D., Tanaka K., Suzuki S., Dembo T., Fukuuchi Y., Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke 2001 32 5 1208 1215 2-s2.0-0034845295 (Pubitemid 32825812)
51. Sandhir R., Onyszchuk G., Berman N. E. J., Exacerbated glial response in the aged mouse hippocampus following controlled cortical impact injury. Experimental Neurology 2008 213 2 372 380 2-s2.0-51549101179 10.1016/j.expneurol.2008.06.013
52. Qin L., Wu X., Block M. L., Liu Y., Breese G. R., Hong J.-S., Knapp D. J., Crews F. T., Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007 55 5 453 462 2-s2.0-33847759064 10.1002/glia.20467 (Pubitemid 46383175)
53. André C., O'Connor J. C., Kelley K. W., Lestage J., Dantzer R., Castanon N., Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administration. Journal of Neuroimmunology 2008 200 1-2 90 99 2-s2.0-50049113248 10.1016/j.jneuroim.2008. 06.011
54. Puentener U., Booth S. G., Perry V. H., Teeling J. L., Long-term impact of systemic bacterial infection on the cerebral vasculature and microglia. Journal of Neuroinflammation 2012 9 146 10.1186/1742-2094-9-146
55. Reyes T. M., Fabry Z., Coe C. L., Brain endothelial cell production of a neuroprotective cytokine, interleukin-6, in response to noxious stimuli. Brain Research 1999 851 1-2 215 220 2-s2.0-0033397024 10.1016/S0006-8993(99)02189-7 (Pubitemid 30038147)
56. Capuron L., Miller A. H., Immune system to brain signaling: neuropsychopharmacological implications. Pharmacology and Therapeutics 2011 130 2 226 238 2-s2.0-79953662385 10.1016/j.pharmthera.2011.01.014
57. Banks W. A., Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Current Pharmaceutical Design 2005 11 8 973 984 2-s2.0-14744289048 10.2174/1381612053381684 (Pubitemid 40331299)
58. Jaeger L. B., Dohgu S., Sultana R., Lynch J. L., Owen J. B., Erickson M. A., Shah G. N., Price T. O., Fleegal-Demotta M. A., Allan Butterfield D., Banks W. A., Lipopolysaccharide alters the blood-brain barrier transport of amyloid b protein: a mechanism for inflammation in the progression of Alzheimer's disease. Brain, Behavior, and Immunity 2011 25 8 1737 2-s2.0-80053897656 10.1016/j.bbi.2010.11.019
59. Verma S., Nakaoke R., Dohgu S., Banks W. A., Release of cytokines by brain endothelial cells: a polarized response to lipopolysaccharide. Brain, Behavior, and Immunity 2006 20 5 449 455 2-s2.0-33746290830 10.1016/j.bbi.2005. 10.005 (Pubitemid 44175796)
60. Banks W. A., Ortiz L., Plotkin S. R., Kastin A. J., Human interleukin (IL) 1 α murine IL-1 α and murine IL-1 β are transported from blood to brain in the mouse by a shared saturable mechanism. Journal of Pharmacology and Experimental Therapeutics 1991 259 3 988 996 2-s2.0-0026334912
61. Bay-Richter C., Janelidze S., Hallberg L., Brundin L., Changes in behaviour and cytokine expression upon a peripheral immune challenge. Behavioural Brain Research 2011 222 1 193 199 2-s2.0-79954603875 10.1016/j.bbr.2011.03.060
62. Quan N., Whiteside M., Herkenham M., Time course and localization patterns of interleukin-1 β messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience 1998 83 1 281 293 2-s2.0-0032031630 10.1016/S0306-4522(97)00350-3 (Pubitemid 28068057)
63. Castanon N., Médina C., Mormède C., Dantzer R., Chronic administration of tianeptine balances lipopolysaccharide-induced expression of cytokines in the spleen and hypothalamus of rats. Psychoneuroendocrinology 2004 29 6 778 790 2-s2.0-1942445129 10.1016/S0306-4530(03)00142-2 (Pubitemid 38521240)
64. Salazar A., Gonzalez-Rivera B. L., Redus L., Parrott J. M., O'Connor J. C., Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge. Hormones and Behavior 2012 62 3 202 209 2-s2.0-84859930998 10.1016/j.yhbeh.2012.03.010
65. Deak T., Bellamy C., D'Agostino L. G., Rosanoff M., McElderry N. K., Bordner K. A., Behavioral responses during the forced swim test are not affected by anti-inflammatory agents or acute illness induced by lipopolysaccharide. Behavioural Brain Research 2005 160 1 125 134 2-s2.0-17044404185 10.1016/j.bbr.2004.11.024
66. Maes M., Yirmyia R., Noraberg J., Brene S., Hibbeln J., Perini G., Kubera M., Bob P., Lerer B., Maj M., The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metabolic Brain Disease 2009 24 1 27 53 2-s2.0-57749179191 10.1007/s11011-008-9118-1
67. Kubera M., Curzytek K., Duda W., Leskiewicz M., Basta-Kaim A., Budziszewska B., Roman A., Zajicova A., Holan V., Szczesny E., Lason W., Maes M., A new animal model of (chronic) depression induced by repeated and intermittent lipopolysaccharide administration for 4months. Brain, Behavior, and Immunity 2013 31 96 104 10.1016/j.bbi.2013.01.001